Nabriva Therapeutics plc Selling, General and Administrative Expense
Nabriva Therapeutics plc reported Selling, General and Administrative Expense of $4.11 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-10-19.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2023-10-19
- Nabriva Therapeutics plc selling, general and administrative expense for the quarter ending 2023-06-30 was $4.11M, a 62.82% decline year-over-year.
- Nabriva Therapeutics plc selling, general and administrative expense for the quarter ending 2023-03-31 was $9.00M, a 29.12% decline year-over-year.
- Nabriva Therapeutics plc selling, general and administrative expense for the quarter ending 2022-12-31 was $9.61M, a 33.67% decline year-over-year.
- Nabriva Therapeutics plc selling, general and administrative expense for the quarter ending 2022-09-30 was $11.91M, a 2.85% decline year-over-year.
- Nabriva Therapeutics plc selling, general and administrative expense for fiscal 2022 was $45.26M, a 12.36% decline from fiscal 2021.
- Nabriva Therapeutics plc selling, general and administrative expense for fiscal 2021 was $51.65M, a 6.58% decline from fiscal 2020.
- Nabriva Therapeutics plc selling, general and administrative expense for fiscal 2020 was $55.28M, a 11.52% decline from fiscal 2019.
- Nabriva Therapeutics plc selling, general and administrative expense for fiscal 2019 was $62.48M, a 49.69% increase from fiscal 2018.
| Period end | Selling, General and Administrative Expense 1 month | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|---|---|---|---|
| 2023-06-30 | $4.11M 10-Q · filed 2023-10-19 | $13.11M 10-Q · filed 2023-10-19 | $22.72M derived: sum of 3 quarters · filed 2023-10-19 | $34.63M derived: sum of 4 quarters · filed 2023-10-19 | ||||
| 2023-03-31 | $9.00M 10-Q · filed 2023-05-22 | $18.61M derived: sum of 2 quarters · filed 2023-05-22 | $30.52M derived: sum of 3 quarters · filed 2023-05-22 | $41.57M derived: sum of 4 quarters · filed 2023-10-19 | ||||
| 2022-12-31 | $9.61M derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $21.52M derived: sum of 2 quarters · filed 2023-04-17 | $32.56M derived: sum of 3 quarters · filed 2023-10-19 | $45.26M 10-K · filed 2023-04-17 | ||||
| 2022-09-30 | $11.91M 10-Q · filed 2022-11-10 | $22.95M derived: sum of 2 quarters · filed 2023-10-19 | $35.65M 10-Q · filed 2022-11-10 | $50.14M derived: sum of 4 quarters · filed 2023-10-19 | ||||
| 2022-06-30 | $11.05M 10-Q · filed 2023-10-19 | $23.75M 10-Q · filed 2023-10-19 | $38.23M derived: sum of 3 quarters · filed 2023-10-19 | $50.49M derived: sum of 4 quarters · filed 2023-10-19 | ||||
| 2022-03-31 | $12.70M 10-Q · filed 2023-05-22 | $27.19M derived: sum of 2 quarters · filed 2023-05-22 | $39.44M derived: sum of 3 quarters · filed 2023-05-22 | $52.30M derived: sum of 4 quarters · filed 2023-05-22 | ||||
| 2021-12-31 | $14.49M derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $26.74M derived: sum of 2 quarters · filed 2023-04-17 | $39.60M derived: sum of 3 quarters · filed 2023-04-17 | $51.65M 10-K · filed 2023-04-17 | ||||
| 2021-09-30 | $12.26M 10-Q · filed 2022-11-10 | $25.11M derived: sum of 2 quarters · filed 2022-11-10 | $37.16M 10-Q · filed 2022-11-10 | $54.68M derived: sum of 4 quarters · filed 2023-04-17 | ||||
| 2021-06-30 | $12.85M 10-Q · filed 2022-08-03 | $24.90M 10-Q · filed 2022-08-03 | $42.42M derived: sum of 3 quarters · filed 2023-04-17 | $53.42M derived: sum of 4 quarters · filed 2023-04-17 | ||||
| 2021-03-31 | $12.05M 10-Q · filed 2022-05-05 | $29.57M derived: sum of 2 quarters · filed 2023-04-17 | $40.57M derived: sum of 3 quarters · filed 2023-04-17 | $51.31M derived: sum of 4 quarters · filed 2023-04-17 | ||||
| 2020-12-31 | $17.52M derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $28.52M derived: sum of 2 quarters · filed 2023-04-17 | $39.26M derived: sum of 3 quarters · filed 2023-04-17 | $55.28M 10-K · filed 2023-04-17 | ||||
| 2020-09-30 | $11.00M 10-Q · filed 2021-11-09 | $21.74M derived: sum of 2 quarters · filed 2021-11-09 | $37.76M 10-Q · filed 2021-11-09 | $35.09M 10-Q · filed 2020-11-05 | $54.91M derived: sum of 4 quarters · filed 2022-03-29 | |||
| 2020-06-30 | $10.74M 10-Q · filed 2021-08-05 | $8.07M 10-Q · filed 2020-08-06 | $26.77M 10-Q · filed 2021-08-05 | $24.10M 10-Q · filed 2020-08-06 | $43.91M derived: sum of 3 quarters · filed 2022-03-29 | $62.41M derived: sum of 4 quarters · filed 2022-03-29 | ||
| 2020-04-30 | $676.00K 10-Q · filed 2020-08-06 | |||||||
| 2020-03-31 | $16.02M 10-Q · filed 2021-05-06 | $33.17M derived: sum of 2 quarters · filed 2022-03-29 | $51.67M derived: sum of 3 quarters · filed 2022-03-29 | $65.10M derived: sum of 4 quarters · filed 2022-03-29 | ||||
| 2019-12-31 | $17.15M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $35.65M derived: sum of 2 quarters · filed 2022-03-29 | $49.08M derived: sum of 3 quarters · filed 2022-03-29 | $62.48M 10-K · filed 2022-03-29 | ||||
| 2019-09-30 | $18.50M 10-Q · filed 2020-11-05 | $31.93M derived: sum of 2 quarters · filed 2020-11-05 | $45.34M 10-Q · filed 2020-11-05 | $55.53M derived: sum of 4 quarters · filed 2021-03-11 | ||||
| 2019-06-30 | $13.43M 10-Q · filed 2020-08-06 | $26.84M 10-Q · filed 2020-08-06 | $37.02M derived: sum of 3 quarters · filed 2021-03-11 | $49.61M derived: sum of 4 quarters · filed 2021-03-11 | ||||
| 2019-03-31 | $13.41M 10-Q · filed 2020-05-11 | $23.60M derived: sum of 2 quarters · filed 2021-03-11 | $36.18M derived: sum of 3 quarters · filed 2021-03-11 | |||||
| 2018-12-31 | $10.19M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $22.77M derived: sum of 2 quarters · filed 2021-03-11 | $41.74M 10-K · filed 2021-03-11 | |||||
| 2018-09-30 | $12.58M 10-Q · filed 2019-11-12 | $31.55M 10-Q · filed 2019-11-12 | ||||||
| 2017-12-31 | $29.47M 10-K · filed 2020-03-12 |